Mohr Marshall's Form 4 filing
Intuitive Surgical Inc (ISRG) · filed Feb 29, 2024
- Accession no.
- 0001035267-24-000087
- Filed
- Feb 29, 2024
- Trade date
- Feb 28-29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 22 non-derivative transactions and 11 derivative transactions. Open-market sales total $41.9M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mohr MarshallCIK 0001252986 | Officer (Executive VP Global Business S) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +13,530 | $242.34 | +$3,278,860.2 | 40,407 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −13,530 | $385.08F2 | −$5,210,132.4 | 26,877 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +13,530 | $177.99 | +$2,408,204.7 | 40,407 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −13,530 | $385.08F2 | −$5,210,132.4 | 26,877 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +10,500 | $166.62 | +$1,749,510 | 37,377 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −10,500 | $385.08F2 | −$4,043,340 | 26,877 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +12,750 | $174.26 | +$2,221,815 | 39,627 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −12,750 | $385.08F2 | −$4,909,770 | 26,877 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +12,750 | $139.52 | +$1,778,880 | 39,627 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −12,750 | $385.08F2 | −$4,909,770 | 26,877 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +22,500 | $109.49 | +$2,463,525 | 49,377 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −14,620 | $385.09F3 | −$5,630,015.8 | 34,757 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +22,500 | $79.64 | +$1,791,900 | 57,257 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −13,750 | $385.08F4 | −$5,294,850 | 43,507 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +11,250 | $77.00 | +$866,250 | 54,757 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −6,860 | $385.08F5 | −$2,641,648.8 | 47,897 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseAcquired | +10,500 | $182.83 | +$1,919,715 | 58,397 | Direct | |
| Feb 28, 2024 | Common Stock | SSaleDisposed | −10,500 | $385.08F2 | −$4,043,340 | 47,897 | Direct | |
| Feb 29, 2024 | Common Stock | MOption exerciseAcquired | +2,253 | $0.00 | $0 | 50,150 | Direct | |
| Feb 29, 2024 | Common Stock | FTax withholdingDisposed | −1,142 | $386.59 | −$441,485.78 | 49,008 | Direct | |
| Feb 29, 2024 | Common Stock | MOption exerciseAcquired | +1,003 | $0.00 | $0 | 50,011 | Direct | |
| Feb 29, 2024 | Common Stock | FTax withholdingDisposed | −509 | $386.59 | −$196,774.31 | 49,502 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −11,250 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −22,500 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −22,500 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −12,750 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −10,500 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −12,750 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −13,530 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −10,500 | $0.00 | $0 | 0 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −13,530 | $0.00 | $0 | 0 | Direct | |
| Feb 29, 2024 | Common Stock | MOption exerciseDisposed | −2,253 | $0.00 | $0 | 0 | Direct | |
| Feb 29, 2024 | Common Stock | MOption exerciseDisposed | −1,003 | $0.00 | $0 | 2,004 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 6 transactions in Table I.
- F3
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.